Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 45,989,301
Avg Vol 115,232,406
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 15%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA (famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment of synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 12 3543 0000
Address:
60 Jubilee Avenue, Milton Park, Abingdon, United Kingdom
Hodl707
Hodl707 Jun. 25 at 12:20 AM
0 · Reply
duepillagence
duepillagence Jun. 24 at 9:24 PM
$ADAPY Notice that it doesn't say "no new filings, reports financial announcements etc..." What about merger?🤔
2 · Reply
US_Bull
US_Bull Jun. 24 at 7:30 PM
$ADAPY Us loyal longs survived f'ery 5 times hitting 0.0001$ on the expert market where our balance was between 50-100$ lol but did we panic sell hell no cause we believed in the science and now the science is paying off!!!
0 · Reply
US_Bull
US_Bull Jun. 24 at 7:27 PM
$ADAPY My guess is it touches 5 plus c's today.
2 · Reply
ricoti
ricoti Jun. 24 at 7:02 PM
$ADAPY Looks like your half the days volume.
1 · Reply
US_Bull
US_Bull Jun. 24 at 3:35 PM
$ADAPY May be the last week before the TSA ends next week befor eit flies, which is why I loaded up I was waiting for the right dip and day to complete my last batch purchase.
0 · Reply
US_Bull
US_Bull Jun. 24 at 3:09 PM
$ADAPY The greater picture is the proof of concept of the entire vector platform to make tons more higher efficacy TCR for a plurality of hard to treat solid tumors!
1 · Reply
US_Bull
US_Bull Jun. 24 at 3:07 PM
$ADAPY Slowly starting to hit the wires all over the internet when they find out they will chase it. In the meantime Tecelra full approval will aid kicking in MS payments not to forget the phenomenal never before seen HCC data and 37.5 month overall survival in exceptionally hard to treat solid tumors. First company ever to offer kids who have synovial sarcoma extension of their lives!
0 · Reply
US_Bull
US_Bull Jun. 24 at 2:57 PM
$ADAPY Averaged down to 6.9 c now.
1 · Reply
US_Bull
US_Bull Jun. 24 at 2:51 PM
$ADAPY That was me guys ;)
1 · Reply
Latest News on ADAPY
No data available.
Hodl707
Hodl707 Jun. 25 at 12:20 AM
0 · Reply
duepillagence
duepillagence Jun. 24 at 9:24 PM
$ADAPY Notice that it doesn't say "no new filings, reports financial announcements etc..." What about merger?🤔
2 · Reply
US_Bull
US_Bull Jun. 24 at 7:30 PM
$ADAPY Us loyal longs survived f'ery 5 times hitting 0.0001$ on the expert market where our balance was between 50-100$ lol but did we panic sell hell no cause we believed in the science and now the science is paying off!!!
0 · Reply
US_Bull
US_Bull Jun. 24 at 7:27 PM
$ADAPY My guess is it touches 5 plus c's today.
2 · Reply
ricoti
ricoti Jun. 24 at 7:02 PM
$ADAPY Looks like your half the days volume.
1 · Reply
US_Bull
US_Bull Jun. 24 at 3:35 PM
$ADAPY May be the last week before the TSA ends next week befor eit flies, which is why I loaded up I was waiting for the right dip and day to complete my last batch purchase.
0 · Reply
US_Bull
US_Bull Jun. 24 at 3:09 PM
$ADAPY The greater picture is the proof of concept of the entire vector platform to make tons more higher efficacy TCR for a plurality of hard to treat solid tumors!
1 · Reply
US_Bull
US_Bull Jun. 24 at 3:07 PM
$ADAPY Slowly starting to hit the wires all over the internet when they find out they will chase it. In the meantime Tecelra full approval will aid kicking in MS payments not to forget the phenomenal never before seen HCC data and 37.5 month overall survival in exceptionally hard to treat solid tumors. First company ever to offer kids who have synovial sarcoma extension of their lives!
0 · Reply
US_Bull
US_Bull Jun. 24 at 2:57 PM
$ADAPY Averaged down to 6.9 c now.
1 · Reply
US_Bull
US_Bull Jun. 24 at 2:51 PM
$ADAPY That was me guys ;)
1 · Reply
Maketheworldabetterplace
Maketheworldabetterplace Jun. 24 at 2:02 PM
$ADAPY when can I see the merger
1 · Reply
Stonky_Mcprofitface
Stonky_Mcprofitface Jun. 24 at 11:23 AM
$ADAPY Our lack of in-vivo capabilities means many doctors won’t even consider our treatments but as an investor this is actually good news. Let me tell you why. Chipotle is looking to expand and since they don’t even know what “in-vivo” means, we can sell to them for a premium, paid in untraceable bitcoin coins.
0 · Reply
Dipshit101
Dipshit101 Jun. 24 at 8:04 AM
$ADAPY good news?
4 · Reply
Mcgregor777
Mcgregor777 Jun. 23 at 9:50 PM
$ADAPY and recent news on liver cancer results were already available since January. Seems like more smoke and mirrors
0 · Reply
Mcgregor777
Mcgregor777 Jun. 23 at 9:47 PM
$ADAPY so they’ll get a portion of the $30 million mile stone payments pending other milestones (and assuming revenue follows).
0 · Reply
Dipshit101
Dipshit101 Jun. 23 at 8:06 PM
$ADAPY I just cashed out on some other deal and tomorrow will try to buy 500,000 shares prob get 1500
3 · Reply
Stockinvestor73
Stockinvestor73 Jun. 23 at 4:55 PM
$ADAPY maybe they will disolve the company and pay us adividend,,,,,, they have the cash
2 · Reply
suchislife
suchislife Jun. 23 at 3:54 PM
$ADAPY are we still waiting for a BO?
1 · Reply
CandlestickTradingCo
CandlestickTradingCo Jun. 23 at 3:43 PM
$ADAPY the 30 people they hired from within are probably OUR people lol
1 · Reply
BK217
BK217 Jun. 23 at 2:09 PM
$ADAPY me and US BULL always knew it would play out exactly like this. Our success is guaranteed and just around the corner and will be announced by LinkedIn very soon
1 · Reply
US_Bull
US_Bull Jun. 23 at 1:08 PM
1 · Reply
c2g4
c2g4 Jun. 23 at 12:38 PM
$ADAPY glitch / vision of the future?
1 · Reply